Personalised medicine for childhood cancers in Australia is a step closer thanks to the Zero Childhood Cancer program’s national clinical trial launched today.
Australian children with the most aggressive forms of cancer are set to benefit from a new program that will examine their unique cancer cells to help identify the drugs most likely to help.
With the increasing availability of genetic testing, glimpsing your future risk of disease based on your own genetic makeup is now more tempting that ever.
For more than a decade now, we have been promised that genetic knowledge would personalise our health care. Support for this future vision has been unwavering, despite its slow progress, writes Robyn Ward.
